Bluejay Therapeutics
www.bluejaytx.comThe mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.
Read more
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.
Read more
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Vice President , Head of Regulatory Affairs
Email ****** @****.comPhone (***) ****-****Vice President , Head of Regulatory Affairs
Email ****** @****.comPhone (***) ****-****
Technologies
(5)
Reach decision makers at Bluejay Therapeutics
Free credits every month!
Bluejay Therapeutics FAQ
United States
Pharmaceutical Manufacturing
